Interference of soluble TNF-alpha receptors in immunological detection of tumor necrosis factor-alpha

被引:0
作者
Moreau, E [1 ]
Philippe, J [1 ]
Couvent, S [1 ]
LerouxRoels, G [1 ]
机构
[1] STATE UNIV GHENT HOSP,DEPT CLIN CHEM MICROBIOL & IMMUNOL,B-9000 GHENT,BELGIUM
关键词
cytokines; inflammation; electrochemiluminescence assay; hormone receptors; immunoassays;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We have studied the interference of soluble tumor necrosis factor-alpha receptor p55 (sTNF-R55) on the quantification of tumor necrosis factor-alpha (TNF-alpha) in three immunoassays: the commercially available enzyme amplified-sensitivity immunoassay (EASIA) of Medgenix and the ELISA of Boehringer Mannheim, and an assay based on electrochemiluminescence (ECL) technology. TNF-alpha measurements by EASIA and ELISA were not affected by the presence of sTNF-R55, but results by the ECL method were clearly influenced by the receptor, We then performed a second set of experiments with the ECL system to examine what factors might influence the importance of interference from sTNF-R55 and soluble TNF-alpha receptor p75 (sTNF-R75), which influences TNF-alpha measurements the same as sTNF-R55. We found that extending the incubation time and increasing the concentration of capture antibody decreased the interfering capacity of sTNF-R55 and sTNF-R75. A clear insight into these phenomena is of utmost importance for correct interpretation of cytokine quantification.
引用
收藏
页码:1450 / 1453
页数:4
相关论文
共 50 条
[41]   Salivary Tumor Necrosis Factor-Alpha and Dental Caries in Children and Adolescents [J].
Nazemisalman, Bahareh ;
Jafari, Faezeh ;
Esmaelzadeh, Abdolreza ;
Faghihzadeh, Soghrat ;
Vahabi, Surena ;
Moslemi, Hamidreza .
IRANIAN JOURNAL OF PEDIATRICS, 2019, 29 (01)
[42]   New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis [J].
Breedveld, F .
EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) :233-238
[43]   Role of tumor necrosis factor-alpha in the pathophysiology of idiopathic intracranial hypertension [J].
Fahmy, Ebtesam Mohamed ;
Rashed, Laila Ahmed ;
Mostafa, Riham Hamdy ;
Ismail, Rania Shehata .
ACTA NEUROLOGICA SCANDINAVICA, 2021, 144 (05) :509-516
[44]   Local expression of tumor necrosis factor-alpha on premature rupture of membranes [J].
Roveran, Valquiria ;
Longo Galvao Silva, Maria Antonieta ;
Yamano, Lucia ;
Rodrigues, Lilian Paiva ;
Vasquez, Monica Lopez ;
Piato, Sebastiao .
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2009, 31 (05) :249-253
[45]   Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries [J].
Pocino, Krizia ;
Carnazzo, Valeria ;
Stefanile, Annunziata ;
Basile, Valerio ;
Guerriero, Cristina ;
Marino, Mariapaola ;
Rigante, Donato ;
Basile, Umberto .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
[46]   Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma [J].
Wang, Hongmei ;
Liu, Jianmin ;
Hu, Xuemei ;
Liu, Shanshan ;
He, Baojun .
MEDICAL SCIENCE MONITOR, 2016, 22 :3694-3704
[47]   Dual neuronal response to tumor necrosis factor-alpha following spinal cord injury [J].
Chi, Lingyi ;
Yu, Jin ;
Zhu, Hong ;
Li, Xingang ;
Zhu, Shugan ;
Li, Zhenzhong ;
Pettigrew, L. Creed ;
Grass, David ;
Hickman, James J. ;
Kindy, Mark S. .
NEURAL REGENERATION RESEARCH, 2010, 5 (12) :917-926
[48]   TUMOR NECROSIS FACTOR-ALPHA GENE-EXPRESSION IN HUMAN WHOLE-BLOOD [J].
STRIETER, RM ;
REMICK, DG ;
HAM, JM ;
COLLETTI, LM ;
LYNCH, JP ;
KUNKEL, SL .
JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 47 (04) :366-370
[49]   Tumor Necrosis Factor-alpha Promotes Tumor Growth by Inducing Vascular Endothelial Growth Factor [J].
Jing, Yingying ;
Ma, Nannan ;
Fan, Tingting ;
Wang, Chenyang ;
Bu, Xinxin ;
Jiang, Guocheng ;
Li, Rong ;
Gao, Lu ;
Li, Ding ;
Wu, Mengchao ;
Wei, Lixin .
CANCER INVESTIGATION, 2011, 29 (07) :485-493
[50]   Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells [J].
Patterson, C ;
Perrella, MA ;
Endege, WO ;
Yoshizumi, M ;
Lee, ME ;
Haber, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :490-496